Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
We cycled 2,000 miles from Cornwall to Portugal – with surfboards in tow
19/10/2025
Xi Jinping is preparing to go toe to toe with Donald Trump – and there will only be one winner | Simon Tisdall
19/10/2025
Regulators overlooking toxic Pfas found around Lancashire chemicals plant
19/10/2025
TV tonight : the upbeat Star Trek prequel with a fresh-faced Spock
19/10/2025
The ‘enormous conflict of interest’ at centre of Jared Kushner’s Gaza ceasefire deal
19/10/2025
‘Why are our black boys hurting each other ?’ Letitia Wright on the deaths that inspired her directorial debut
19/10/2025